Maedeh Koohi Moftakhari Esfahani

Years Active: 2020-2022
Publications (10 Years): 5

Knowledge-based company of Zista Pardazan Atiyeh Asre Nano

Queensland University of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Knowledge-based company of Zista Pardazan Atiyeh Asre Nano Feb 01 2014

Iran

Researcher

Pasteur Institute of Iran Dec 01 2011

Iran

Researcher :: Pilot Department of nanobiotechnology

SABZ Biomedicals company Aug 01 2012 - Aug 30 2013

Iran

Researcher

Education History

Queensland University of Technology Feb 01 2019

Australia

PHD :: Translational Research Institute

Islamic Azad University Science and Research Branch Sep 23 2010 - Sep 06 2012

Iran

MSC :: Chemical Engineering-Biotechnology

Islamic Azad University Science and Research Branch Sep 22 2004 - Jan 10 2009

Iran

BSC :: Medical Radiation Engineering

Publications

Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 14 (4) (2022)
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy. Pharmaceutics 14 (8) (2022)
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 13 (10) (2021)
Maedeh Koohi Moftakhari Esfahani, Nazrul Islam, Peter J Cabot, Emad L Izake
Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS biomaterials science & engineering (2021)
Mohsen Ghaferi, Maedeh Koohi Moftakhari Esfahani, Aun Raza, Sitah Alharthi, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. Journal of drug targeting 29 (2) (2020)

Maedeh Koohi Moftakhari Esfahani.css-eqlu8i{font-size:small;padding-left:4px;}